Morra, A., Schreurs, M., Andrulis, I., Anton-Culver, H., Augustinsson, A., Beckmann, M., . . . Hooning, M. (2023). Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Citación estilo ChicagoMorra, A., et al. Association of the CHEK2 C.1100delC Variant, Radiotherapy, and Systemic Treatment With Contralateral Breast Cancer Risk and Breast Cancer-specific Survival. 2023.
Cita MLAMorra, A., et al. Association of the CHEK2 C.1100delC Variant, Radiotherapy, and Systemic Treatment With Contralateral Breast Cancer Risk and Breast Cancer-specific Survival. 2023.
Precaución: Estas citas no son 100% exactas.